Alarming numbers of COVID-19 vaccine recipients are coming down with a new syndrome known as ‘Post-Acute Covid Vaccination Syndrome‘.

One patient was diagnosed with the syndrome after being injected with Pfizer’s (BNT162b2) Covid vaccine, according to a medical case study published in August.

Infowars.com reports: “The patient is a 47-year-old male with a 10-year history of HLA-B27-associated spondylarthritis without recurrence, who developed acute and post-acute COVID vaccination syndrome (ACVS/PACVS) after the first dose of the BNT162b2 vaccine,” the case study said in the ‘Abstract’ section. “The PACVS manifested as cerebral disease, eye disease, and SFN [small fiber neuropathy].”

The new syndrome can strike anyone of any age who takes the shot, arise at an unspecified time and potentially kill them.

“Side effects can manifest as acute COVID vaccination syndrome (ACVS) within hours or a few days after vaccination or as post-acute COVID vaccination syndrome (PACVS) several days or weeks after vaccination. ACVS/PACVS can be mild to fatal and can occur at any age,” the case study said in the ‘Abstract’ section.

Unfortunately for the man, the treatment has been mostly unsuccessful.

“Two years after the onset of the adverse effects, recurrent elevated recoverin antibodies were detected. Despite the administration of various treatments, most symptoms persisted for more than three years, and only a few interventions such as glucocorticoids, hyperbaric oxygen therapy, botulinum toxin, inuspheresis, and HELP (heparin-induced extracorporeal LDL precipitation) apheresis showed a transient beneficial effect,” the case study said in the ‘Abstract’ section.

Side effects of the new syndrome include malaise, chronic fatigue, peripheral nerve dysfunction, dysesthesia (an unpleasant abnormal sense of touch), motor weakness, pain, vasomotor dysfunction, cardiovascular impairment, cognitive impairment, headache and visual or acoustic dysfunctions.

“Post-acute COVID-19 vaccination syndrome (PACVS) is a chronic disease triggered by SARS-CoV-2 vaccination,” a study said in the ‘Abstract’ section. “[Post-acute COVID-19 vaccination syndrome] is discriminated from the normal post-vaccination state by altered receptor antibodies, most notably angiotensin II type 1 and alpha-2B adrenergic receptor antibodies.”

It should be noted that the patient in the case study does have a history of autoimmune disorders, however the new syndrome is not limited solely to those afflicted with such ailments.

“In conclusion, this case offers an example of a collection of symptoms following SARS-CoV-2 vaccination (SC2V) in a patient with a specific autoimmune disorder and positivity for anti-recoverin antibodies. These clinical manifestations may be triggered by an exaggerated immune response known as multisystemic inflammatory syndrome in adults to SC2V,” the case study said in the ‘Abstract’ section.